6 the desired insert. The transformation is achieved by chemical method (Hanahan, 1983; Inoyue, 1997; Bergmans, 1981) or electroporation (Morrison, 2001) .
Chemical transformation
For transformation of bacterial cells by chemical means, the cells are grown to mid-log phase, harvested and treated with divalent cations such as CaCl 2 to make them competent. After mixing DNA with such competent cells, on ice, followed by a brief heat shock at 42 0 C, the cells are incubated with rich medium for 30-60 minutes prior to plating on suitable antibiotic containing LB agar plates. The biggest advantage of this method includes no special equipment for transformation with no requirement to remove salts from the DNA used for transformation.
Electroporation
For electroporation, cells are also grown to mid-log phase but are then washed extensively with water to eliminate all salts from the growth medium, and glycerol added to the water to a final concentration of 10% so that the cells can be stored frozen and saved for future experiments. To electroporate DNA into cells, washed E. coli are mixed with the DNA to be transformed and then pipetted into a plastic cuvette containing electrodes. A short electric pulse, about 2400 volts/cm, is applied to the cells causing small pores in the membrane through which the DNA enters. The cells are then incubated with broth as above before plating. For electroporation, the DNA must be free of all salts so the ligations are first precipitated with alcohol before they are used.
Types of E. coli host cells used for transformation
For most cloning applications, E. coli k12 hosts like DH5 which are OmpT protease expressing cells (Salunkhe etal., 2010) are used. These cells are compatible with lacZ blue/white selection procedures, are easily transformed, and good quality plasmid DNA can be recovered from transformants. DH5 is one of the most preferred strains for plasmid propagation, because it is an EndA1 knockout which inactivates the endonucleases ,and a recA knock out which prevents rapid homologous recombination, hence ensuring that the plasmids are stable inside the cells. One notable exception is when transforming with plasmid constructs containing recombinant genes under control of the T7 polymerase, these constructs are typically transformed into DH5 cells during the cloning stage and later introduced into a bacterial strain expressing T7 RNA polymerase for expression of the recombinant protein. The derivatives available for this purpose include BL21(DE3), BL21A1 which are all lon and OmpT protease negative strains (Banerjee et al., 2009; Mandi et al, 2008) and ER2566 (Yu et al., 2004) strains.
Selection of recombinants
The need to identify the cells that contain the desired insert at the appropriate and right orientation and isolate these from those not successfully transformed is of utmost importance to researchers. Modern cloning vectors include selectable markers (most frequently antibiotic resistance markers) that allow only cells in which the vector, but not necessarily the insert, has been transformed to grow. Additionally, the cloning vectors may contain color selection markers which provide blue/white screening (via -factor complementation) on X-gal medium. Nevertheless, these selection steps do not 7 absolutely guarantee that the DNA insert is present in the cells. Further investigation of the resulting colonies is required to confirm that cloning was successful. This may be accomplished by means of PCR, restriction fragment analysis and/or DNA sequencing. Telford et al., (1977) reported identification of bacterial plasmids carrying DNA upon lysis and mixing with molten agar with ethidium bromide stain while in as early as 1978, a colony hybridization was developed for screening recombinants by Cami and Kourilsky, (1978) where upon blotting onto nitrocellulose filters and hybridization with a highly radioactive probe, screening of many thousands of colonies per plate for the presence of a DNA sequence carried by a plasmid and complementary to the probe was achieved.
Colony immunoassay
An immunological approach to screen recombinant clones is possible if the gene of interest encodes a polypeptide for which specific antibodies can be prepared. In one approach, DNA complementary to mRNA is inserted in frame with the coding regions of genes present in E. coli plasmids. These results in "fused polypeptides" consisting of the N-terminal region of an E. coli polypeptide covalently linked to a sequence encoded by the cloned cDNA segment. The identification of cloned genes by colony immunoassays has not been common and one limitation of all previous colony immunoassays is that each fused polypeptide molecule must simultaneously bind to two different antibody molecules. Typically, the first antibody, immobilized on a solid support such as chemically activated paper, is used to entrap the fused polypeptide at the site of the lysed colony, and a second labelled antibody is then bound to the fused polypeptide and detected by autoradiography. A potential disadvantage of all immunological methods is that only one in six sequences inserted at random into the vector would have the orientation and frame consistent with translation into a recognizable fused polypeptide. Kemp & Cowman (1981) have described a method by which fused polypeptides can be detected by a colony immunoassay that demands binding of only one antibody molecule. E. coli colonies containing recombinant plasmids are lysed in situ, and proteins in the lysate are immobilized by binding directly to CNBr-activated paper. Antigens attached to the paper are then allowed to react with antiserum, and the antibodies that bind to them are in turn detected by reaction with 125 I-labeled protein A ( 125 I-protein A) from Staphylococcus aureus, followed by autoradiography. The limitations of this method are mRNA instability, inefficient translation, or rapid proteolytic degradation of the fused polypeptides that restrict their accumulation within the cells. A simple immunoassay has been developed by Reggie and Comeron (1986) for isolation of particular gene(s) from a clone bank of recombinant plasmids. A clone bank of the DNA is constructed with a plasmid vector in Escherichia coli and filtered onto a hydrophobic grid membrane and grown up into individual colonies, and a replica was made onto nitrocellulose paper. The bacterial cells upon lysis are immobilized onto the nitrocellulose paper which is reacted with a rabbit antibody preparation made against the particular antigenic product to detect the recombinant clone which carries the corresponding gene. The bound antibodies can be detected easily by a colorimetric assay using goat anti-rabbit antibodies conjugated to horseradish peroxidase.
Visual screening 3.2.1 The blue-white screening
The blue white screening is one of the most common molecular techniques that allow detecting the successful ligation of gene of interest in vector (Langley et al., 1975; Zamenhof & Villarejo 1972; Ausubel et al., 1988) . The -Complementation plasmids are among the most commonly used vectors for cloning and sequencing the DNA fragments, as they generally have a good multiple cloning site and an efficient blue-white screening system for identification of recombinants in presence of a histochemical dye, 5-bromo-4-chloro-3indolyl--d-galactoside (X-gal), and binding sites for commercially available primers for direct sequencing of cloned fragments (Manjula 2004) . The molecular mechanism for blue/white screening is based on a genetic engineering of the lac operon in the E. coli as a host cell combined with a subunit complementation achieved with the cloning vector. The lacZ product, a polypeptide of 1029 amino acids, gives rise to the functional enzyme after tetramerization (Jacobson et al., 1994) and is easily detected by chromogenic substrates either in cell lysates or directly on fixed cells in situ (Ko et al., 1990) . The tetramerization is dependent on the presence of the N-terminal region spanning the first 50 residues. Deletions in the N-terminal sequence generate a so-called omega peptide that is unable to tetramerize and does not display enzymatic activity. The activity of the omega peptide can be fully restored either in bacteria or in vitro, if a small fragment (called alpha peptide) corresponding to the intact N-terminal portion is added in trans (Gallagher et al., 1994) . The phenomenon is called α-complementation and the small N-terminal peptide is called alpha peptide. This effect has been widely exploited for studies in prokaryotes, where special strains that constitutively express omega peptide exist and allow the detection of expression of the small alpha peptide. The vector (e.g. pBluescript) encodes the subunit of LacZ protein with an internal multiple cloning site (MCS), while the chromosome of the host strain encodes the remaining omega subunit to form a functional -galactosidase enzyme upon complementation. The foreign DNA can be inserted within the MCS of lacZ gene, thus disrupting the formation of functional -galactosidase. The chemical required for this screen is X-gal, a colorless modified galactose sugar that is metabolized by -galactosidase to form 5-bromo-4-chloroindoxyl which is spontaneously oxidized to the bright blue insoluble pigment 5,5'-dibromo-4,4'-dichloro-indigo and thus functions as an indicator. Isopropyl -D-1thiogalactopyranoside (IPTG) which functions as the inducer of the Lac operon, can be used to enhance the phenotype. The hydrolysis of colorless X-gal by the -galactosidase causes the characteristic blue colour in the colonies indicating that the colonies contain vector without insert. White colonies indicate insertion of foreign DNA and loss of the cells ability to hydrolyze the marker. Bacterial colonies in general, however, are white, and so a bacterial colony with no vector will also appear white. These are usually suppressed by the presence of an antibiotic in the growth medium. Blue white screening is thus a quick and easy technique that allows for the screening of successful cloning reactions through the color of the bacterial colony. However, the correct type of vector and competent cells are important considerations when planning a blue white screen. Although the lacZ and many other systems have been extensively used for gram negative bacteria like E. coli, there are limited options available for screening recombinants transformed in Gram positive bacteria. Chaffin & Rubens (1998) have developed a gram positive cloning vector pJS3, that utilizes the interruption of an alkaline phosphatase gene, phoZ, to identify recombinant plasmids. A multiple cloning site (MCS) was inserted distal to the region coding for the putative signal peptide of phoZ where the alkaline phosphatase protein expressed from the phoZ gene (phoZMCS) retained activity similar to that of the native protein and cells displayed a blue colonial phenotype on agar containing 5-bromo-4-chloro-3-indolyl phosphate (X-p). Introduction of any foreign DNA into the MCS of phoZ produced a white colonial phenotype on agar containing X-p and allowed discrimination between transformants containing recombinant plasmids versus those maintaining self-annealed or uncut vector. This cloning vector has improved the efficiency of recombinant DNA experiments in gram-positive bacteria. Cloning inserts into the multiple cloning region of the pGEMÂ®-Z Vectors disrupts the alpha-peptide coding sequences, and thus inactivates the beta-galactosidase enzyme resulting in white colonies. Recombinant plasmids are transformed into the appropriate strain of bacteria (i.e. JM109, DH5), and subsequently plated on indicator plates containing 0.5 mM IPTG and 40 µg/ml X-gal. A new version of TA cloning vector with directional enrichment and blue-white color screening has been reported by Horn (2005) .
Limitations of blue-white screening
The "blue screen" technique described above suffers from the disadvantage of using a screening procedure (discrimination) rather than a procedure for selecting the clones. Discrimination is based on visually identifying the recombinant within the population of clones on the basis of a color. The LacZ gene, in the vector used for generating recombinants, may be non-functional and may not produce β-galactosidase. As a result, these cells cannot convert X-gal to the blue substance so the white colonies seen on the plate may not be recombinants but just the background vector. A few white colonies might not contain the desired recombinant but a small piece of DNA to be ligated into the vector's MCS might change the reading frame for LacZα, and thus prevent its expression giving rise to false positive clones. Furthermore, a few linearized vectors may get transformed into the bacteria, the ends "repaired" and ligated together such that no LacZ is produced as a result, these cells cannot convert X-gal to the blue substance. On the other hand, in some cases, blue colonies may contain the insert, when the insert is "in frame" with the LacZα gene and is devoid of stop codon. This could sometimes lead to the expression of a fusion protein that is still functional as LacZ . Small inserts which happen to be in frame with the alpha-peptide coding region may produce light blue colonies, as betagalactosidase activity is only partially inactivated. Last but not the least, this complex procedure requires the use of the substrate X-gal which is very expensive, unstable and is cumbersome to use.
Reporter gene based screening
Another method for screening and identification of recombinant clones is by using the green fluorescent protein (GFP) obtained from jellyfish Aequorea victoria. It is a reporter molecule for monitoring gene expression, protein localization, protein-protein interaction etc. GFP has been expressed in bacteria, yeast, slime mold, plants, drosophila, zebrafish and in mammalian cells. Inouye et al., (1997) have described a bacterial cloning vector with mutated Aequorea GFP protein as an indicator for screening recombinant plasmids. The pGREENscript A when expressed in E. coli produced colonies showing yellow color in day light and strong green fluorescence under long-UV. Inserted foreign genes are selected on the basis of loss of the fluorescence caused by inactivation of the GFP production. The vector used in the study is a derivative of pBluescript SK(+) (Short et al., 1998) and encodes for the same MCS flanked by T3 and T7 promoters, but lacks the lacZ gene and the f1 origin region (for single strand DNA production). Instead, the GFP-S65A cDNA is substituted in its place and is under the control of the lac promoter/operator. The insertion of foreign DNAs into MCS of pGreenscript A interferes with the production of GFPS65A and causes a loss in the green fluorescence and yellow color of E. coli colonies. While GFP solubility appears to be one of the limiting factors in whole cell fluorescence, Davis & Vierstra (1998) have reported about soluble derivatives of GFP for use in Arabidopsis thaliana.
A system for direct screening of recombinant clones in Lactococcus lactis, based on secretion of the staphylococcal nuclease (SNase) in the organism, was developed by Loir and co-workers (Loir et al, 1994) . L. lactis strains containing the nuc' plasmids secrete SNase and are readily detectable by a simple plate test. An MCS was introduced just after the cleavage site between leader peptide and the mature SNase, without affecting the nuclease activity. Cloning foreign DNA fragments into any site of the MCS interrupts nuc gene and thus results in nuc mutant clones which are easily distinguished from nuc' clones on plates. The biggest advantage of this vector is the possibility of assessing activity of the fusion protein since the nuclease activity is not diminished by its N-terminal tail and is also reported to be unaffected by denaturing agents such as sodium dodecyl sulfate (SDS) or trichloroacetic acid.
Limitations of the reporter gene based screening
All the above described plasmids could also result in false positive clones, which is a major concern for researchers. Loss of GFP fluorescence due to medium composition is also known to lead to false positive results. Although the SNase based screening would give absolute 100% recombinants, the active nuc fusion protein expression might render the cell fragile and enhance its susceptible to the lethal action of the fusion protein upon hyper expression. Also, for all the above cases, there is a requirement of transfer the genes of interest from the cloning vector to the expression vectors which calls for fresh cloning followed by screening for recombinants. Hence, it is evident that the commonly used method for screening and identification of recombinant clones are associated with problems of false positive results forcing researchers to look for alternate methods of screening bacterial recombinants and availability of vectors that would act both as cloning vectors and expression vector are user friendly and advantageous.
Reporter gene based screening-new concepts
The recent approach of screening recombinants is the use of vector for one-step screening and expression of foreign genes (Fig. 1) . The strategy uses the cloning of GFP gene into any expression vector with a stop codon other than the amber stop codon upstream of the ORF of GFP. Upon induction, the GFP would not express and hence would not fluoresce due to presence of the stop codon. Upon in frame cloning of any gene of interest upstream of GFP in such a vector, would then excise the initial stop codon and the resultant fusion protein would fluoresce. The gene of interest contains an amber stop codon and the recombinant screening is carried out in an amber suppressor E. coli strain. For expression studies, the same clone can be used for expression in a non amber suppressor E. coli host like LE392 cells.
This report describes a vector where screening the transformants in situ for the presence of recombinants is possible without any false positive results. All other commercially available vectors show loss of color or loss of fluorescence that may not be unfailing while the major advantage of the vector described in this report, takes the property of color or fluorescence obtained after cloning. This unique vector would also be applicable with any other reporter genes like beta galactosidase gene, luciferase gene, DsRed protein instead of the described gene for GFP in the same vector constructed similarly. It also provides researchers to skip setting up the control ligation mix (without insert) and the dephosphorylation step (CIP or SAP step) since the religated vector would never glow and all the fluorescing colonies are indicative of only the recombinants and also indicative of correct reading frame of the inserted target gene. Since GFP fluorescence is brightest when it is expressed in soluble form (Davis & Vierstra 1998) , the intensity of the fluorescence after cloning any foreign gene would also indicate the extent of solubility of the fusion protein. The major advantage of the vector described in this report, takes the property of color or fluorescence obtained after cloning, which is hitherto unreported. Such a vector used for identification, selection and expression of recombinants has been patented by the authors (Deshpande etal., 2010) and is published under PCT (Patent no. WO2010/0226601A2) Fig. 1 . Plasmid map of the vector pET21aM-GFPm that carries the reporter gene GFP at the 3' end of the MCS. Amp R refers to ampicillin resistant marker gene.
Screening clones by positive selection
A variety of positive selection cloning vectors has been developed that allow growth of only those bacterial colonies that carry recombinant plasmids. Typically, these plasmids express a gene product that is lethal for certain bacterial hosts and insertion of any DNA fragment that insertionally inactivates the expression of the toxic gene product resulting in growth of colonies.
Positive selection has been a powerful method of screening insert containing transformants.
Here the toxic property of the molecule to the host cells is utilized for recombinant selection. The DNA sequence coding for the toxic product is directly cloned under the promoter elements recognized by the host cells. Positive selection in these vectors is achieved by either inactivation or replacement of toxic gene by the target gene. In general former is much more convenient than the latter (For a detailed review on positive selection vectors ; see reference Choi et al., 2002) . The advantage of these systems is that no background colonies (non recombinants) appear on vector alone plates since the religated vectors carrying toxic intact genes are lethal to the host cells. The genes of toxin-antitoxin system (Finbarr, 2003) of E. coli are being utilized for the development of positive selection vectors. A cloning vector carrying cloned ccdB gene which encodes poisonous topoisomerase II (DNA gyrase) causing unrecoverable DNA damage has been develope d and is widely used as zero back g round cloning k it from Invitrog en (Bernard 1995) . The other toxins from this system which are used successfully are parD and parE toxins (Gabant et al., 2000; Kim et al., 2004) . Apart from this system, the other toxic gene used for the development of positive selection vectors are Colicin E3 and mutated form (E181Q) of catabolite activator protein (Ohashi-Kunihoro et al., 2006; Schlieper et al., 1998) . These powerful selection strategies, however, are often only suitable for cloning and require a special host strain for propagation which carry a gene encoding antidote to the product of toxic gene. The authors of this chapter have developed a positive selection vector which would be used for cloning and expression of heterologous genes simultaneously . Here the toxic gene is derived from the antisense strand of ccdB gene and cloned under tightly regulated araBAD promoter downstream to the multiple cloning sites (Fig. 2) . Multiple cloning sites facilitate cloning of foreign genes and doesn't affect the lethality of toxic gene. A simple method is used to screen the recombinants in that the transformed cells are plated on LB agar medium containing 13 mM arabinose. Moreover, this vector is used also for the expression of genes with authentic N-terminus and does not require special host strain for its propagation. Recently, Haag & Ostermeier (2009) have also reported the development of a novel positive selection vector, RHP-Amp s , that is suitable for cloning and high level protein expression in E. coli. Although some limitations exist, positive selection vectors are useful in recombinant DNA experiments thereby reducing the time, effort and cost spent on identifying the correct clones. Some of other well documented lethal genes include bacteriophage λ repressor, EcoRI methylase, EcoRI endonuclease, galactokinase, colicin E3, transcription factor GATA-1, lysis protein of φX174, barnase (Sambrook et al, 1989) , SacB protein of Bacillus subtilis (Gay et al., 1985) , RpsL protein of E. coli (Hashimoto-Gotoh et al., 1993) , and also the ParD system of the R1 plasmid (Gabant et al., 2000) . A recently described strategy by Manjula, (2004) involves the use of galactose sensitivity exhibited by galactose epimerase (galE) mutants of Escherichia coli. Here, the E. coli cells that are lacZ+ galE, but not lacZ− galE are killed upon addition of lactose due to the accumulation of a toxic intermediate, UDP-galactose, by hydrolysis of lactose. Such a method has been suggested to be useful during primary cloning experiments such as construction of genomic or cDNA libraries and also in instances involving selection for rare recombinants. 
Potential limitations of screening recombinants based on positive selection
Requirements of tightly controlled promoter for expression of the anti-dote of the lethal gene. Requirements of special host cells for the lethal gene inserted or integrated in the bacterial genome is also one of the potential drawbacks and renders this system with limited applications. Moreover, since different genes respond to different promoters, requiring different kinds of host RNA polymerases, the modification of the host with the required lethal gene becomes a prerequisite with various genes which involves cost and is timeconsuming. However, for efficient positive selection, the lethality of the marker gene must be strong enough to completely kill the clones harboring vector without insert.
Prediction of solubility of recombinant clones during screening
The structural and functional genomics require large supply of soluble, pure and functional proteins for high throughput analysis and as far as screening of soluble or insoluble recombinants is concerned, soluble protein production in E. coli is still a major bottleneck for investigators and a couple of efforts have been reported to improve the solubility or folding of recombinant protein produced in E. coli (Smith 2007) . These include strategies like co-expression of chaperone proteins such as GroES, GroEL, DnaK and DnaJ lowering incubation temperature, use of weak promoters, addition of sucrose and betaine in a growth media, use of a richer media with phosphate buffer such as terrific broth (TB), use of signal sequence to export the protein to the periplasmic fraction, fermentation at extreme pH's and use of fusion tags to aid in expression and protein purification (De Marco et al., 2004) . A colony filtration (CoFi) blot method for rapid identification of soluble protein expression in E. coli, based on a separation of soluble protein from inclusion bodies by a filtration step at the colony level is described to screen a deletion mutagenesis library by Cornvik et al., (2005) while Coleman et al (2004) report a fluorescent based screening of soluble protein expression where specifically labeled proteins in cellular lysates are detected in one of three formats: a microplate using a fluorescence plate reader, a dot-blot using a fluorescence scanner or a microarray using a laser scanner. Fusion tags have become indispensable tools for structural and functional proteomics initiatives . Fusion tags that are available for the ease of expression and purification of recombinant proteins include His tag (6-10 aa) , thioredoxin (109 aa) (Lavallie et al., 1993) , Glutathione S-transferase (236 aa) (Smith & Johnson 1988) , maltose binding protein (363 aa) (di Guan et al., 1998) , NusA (435 aa) (Davis et al., 1999) etc. Although these tags are mainly used to promote the solubility of the target proteins and there by prevent the formation of inclusion bodies in E. coli, its use in screening recombinants for solubility of protein of interest is also demonstrated. Maxwell et al., (1999) report cloning of a gene of interest as chloramphenicol acyl transferase (CAT) fusion. Based on the resistance to higher concentration of chloramphenicol, it would be easier to predict the solubility of target protein. The authors have developed an in vivo system for assessing protein or protein domain of interest with CAT, the enzyme responsible for conferring bacterial resistance to chloramphenicol. CAT is highly soluble homodimeric protein that has shown to maintain activity when fused to various other proteins. It has been observed that CAT fusions to insoluble proteins confer lower chloramphenicol resistance than that of a fusion with highly soluble partner. Similarly, Banerjee et al., (2010) have shown that the solubility of the target protein could be predicted in situ at the time of recombinant screening based on the intensity of the GFP fusion proteins. This work demonstrates that higher the solubility of the target protein , the intensity of the GFP fluorescence on the agar plate is higher rendering the screening of the recombinants a dual objective of identification and also predicting the solubility of the gene of interest attached to the reporter gene. The article as described by Banerjee et al., (2010) demonstrates this clearly. While GCSF, a human granulocyte colony stimulating factor gene which is known to get expressed as insoluble aggregates in E. coli shows lesser fluorescence as GFP fusion (Figure 3, panel B ) the E. coli methionine amino peptidase, the well soluble E. coli protein exhibits higher intensity of GFP fusion (Figure 3 A similar strategy has been reported by Colman and Homes (2005) for integration confirmation in Pseudomonas strains. Here a pUC-based reporter plasmid (pUS23) was developed containing a recombination site [aadB 59 base element (59-be)] upstream of promoterless aadB [gentamicin (Gm) resistance] and gfp (green fluorescence) genes, and this construct was used to investigate the recombination and expression activities of the CI in Pseudomonas stutzeri strain Q capture of pUS23 at attI by an integron results in Pcmediated expression of the aadB and gfp genes, which are silent in the initial construct. The final end result is gentamicin resistant and green fluorescent recombinants for positive integrants.
Conclusions
In this article, we have summarized some updated information about (1) new vectors that are commercially available to make the screening system of bacterial recombinants antibiotic free (2) new concepts about easy screening of recombinants utilizing the solubility property of the protein of interest and (3) specialized host strains and using the same clone for expression studies. Developments in recombinant DNA technology have allowed rapid progress in the analysis of gene structure and function, and the production of potentially useful polypeptides in Escherichia coli. Often the experimentally limiting step has been the lack of a suitable screening methodology for expressed cDNAs. The extensive variety of screening bacterial colonies for recombinant plasmids arises from the fact that there is no single method for achieving fool-proof recombinant clone. Conventionally the screening methods employed routinely in academia and industry, for bacterial recombinants include colony hybridization, PCR and plasmid preparations. While all the methods involve cloning the gene of interest in a cloning vehicle and then reintroduction of the recombinant clone into another host cell for expression of the interest making the entire process time-consuming, laborious and expensive. While colony hybridizations require several days to a week and may involve the use of radioactivity, PCR based methods are expensive and have lengthy set-up and reaction times, plasmid preps require considerable hours for cell growth and preparation of mini-prep plasmids. An additional step of screening such recombinants for the solubility of the protein of interest makes the entire process labor-intensive and challenging.
